Risk factors for post‐transplant mortality in recipients with grade 3 acute‐on‐chronic liver failure: analysis of a North American consortium

2022 ◽  
Author(s):  
Vinay Sundaram ◽  
Sarvanand Patel ◽  
Kirti Shetty ◽  
Christina C. Lindenmeyer ◽  
Robert S. Rahimi ◽  
...  
Keyword(s):  
Risk Factors ◽  
Liver Failure ◽  
Failure Analysis ◽  
North American ◽  
Chronic Liver ◽  
Chronic Liver Failure ◽  
Post Transplant ◽  
Grade 3

PS-212-Liver transplantation in patients with grade 3 acute-on-chronic liver failure: Pre-transplant risk factors of post-transplant mortality

2019 ◽  
Vol 70 (1) ◽  
pp. e140
Author(s):  
Thierry Artzner ◽  
Baptiste Michard ◽  
Emmanuel Weiss ◽  
Louise Barbier ◽  
Zaid Noorah ◽  
...  
Keyword(s):  
Risk Factors ◽  
Liver Transplantation ◽  
Liver Failure ◽  
Chronic Liver ◽  
Chronic Liver Failure ◽  
Post Transplant ◽  
Grade 3

Liver transplantation in the most severely ill cirrhotic patients: A multicenter study in acute-on-chronic liver failure grade 3

2017 ◽  
Vol 67 (4) ◽  
pp. 708-715 ◽  
Author(s):  
Florent Artru ◽  
Alexandre Louvet ◽  
Isaac Ruiz ◽  
Eric Levesque ◽  
Julien Labreuche ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Liver Failure ◽  
Multicenter Study ◽  
Chronic Liver ◽  
Chronic Liver Failure ◽  
Cirrhotic Patients ◽  
Grade 3

Share MELD-35 does not fully address the high waiting list mortality of patients with acute on chronic liver failure grade 3

2020 ◽  
Vol 73 ◽  
pp. S8-S9
Author(s):  
Vinay Sundaram ◽  
Parth Shah ◽  
Constantine Karvellas ◽  
Sumeet Asrani ◽  
Robert Wong ◽  
...  
Keyword(s):  
Liver Failure ◽  
Chronic Liver ◽  
Waiting List ◽  
Chronic Liver Failure ◽  
Grade 3

Chronic Hepatic Failure

2019 ◽  
Author(s):  
Derek J Erstad ◽  
Motaz Qadan
Keyword(s):  
Risk Factors ◽  
Hepatocellular Carcinoma ◽  
Liver Transplantation ◽  
Portal Hypertension ◽  
Hepatic Encephalopathy ◽  
Liver Failure ◽  
Chronic Liver ◽  
Chronic Liver Failure ◽  
End Stage Liver Disease ◽  
End Stage

Continued hepatic injury by genetic or environmental factors results in a state of chronic inflammation, fibrosis, and progressive hepatocyte dysfunction that can progress to cirrhosis and end stage liver disease (ESLD). Cirrhosis is the eighth leading cause of mortality in the United States, while the burden of disease is even greater in regions with endemic viral hepatitis. Common risk factors include a history of hepatitis; alcohol or IV drug abuse; use of certain medications; and other risk factors associated with transmission of viral hepatitis, including tattoos, sexual promiscuity, and incarceration. Although many patients with cirrhosis are asymptomatic and remain undiagnosed, many will eventually develop secondary complications from chronic liver failure, which can be difficult to manage and are associated with significant morbidity, including: portal hypertension, variceal bleeding, coagulopathy, hepatic encephalopathy, and renal failure. In addition, hepatocellular carcinoma (HCC) is estimated to be 30 times more common among patients with cirrhosis, which can be an aggressive malignancy with 5-year overall survival of less than 15%. In this chapter, we provide a comprehensive overview of chronic liver failure, including the epidemiology of cirrhosis, pathophysiology of liver injury, and assessment and management of cirrhosis and associated downstream complications. Finally, we discuss the role of liver transplantation for both ESLD and HCC. This review contains 6 figures, 9 tables, and 53 references. Key Words: chronic liver failure, cirrhosis, coagulopathy, end stage liver disease, hepatic encephalopathy, hepatocellular carcinoma, hepatorenal syndrome, liver transplantation, portal hypertension, varices

Sign in / Sign up

Export Citation Format

Share Document